Bayer Symposium Thursday 4th

“Redefining Cardiovascular Care for Patients with Atherosclerosis”

Chairs: Christoph Bode, Bianca Rocca 

Faculty: Victor Aboyans, Hector Bueno, Dirk Sibbing 

Time Topic Presenter
12:30 Opening Remarks Christoph Bode
12:35 Residual Risk Reduction in CAD: Current Outlook and Future Prospects Héctor Bueno
12:50 New Directions for Vascular Protection in PAD Victor Aboyans
13:05 What Does COMPASS Mean for my Patient? Dirk Sibbing
13:20 Q&A and Closing Remarks Bianca Rocca


Boehringer Ingelheim Symposium Friday 5th

“Patient life beyond thromboembolic risk”

Chairs: Andrea Rubboli, Gemma Vilahur

Faculty: Giulia Renda, Andrea Rubboli, Paolo Verdecchia

Time Topic Presenter
12:30 Opening Remarks Andrea Rubboli
12:35 From phase III trials to real world evidence: do NOACs confirm their safety and effectiveness profile? Giulia Renda
12:50 From left ventricular hypertrophy to atrial fibrillation Paolo Verdecchia
13:05 Modulating the intensity of oral anticoagulation with NOACs in atrial fibrillation: how and when Andrea Rubboli
13:20 Q&A and Closing Remarks Gemma Vilahur